THU0234 INFLUENCE OF THE SPLICING MACHINERY DYSREGULATION ON THE PATHOGENESIS OF LUPUS AND THE KIDNEY INVOLVEMENT
C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), N. Barbarroja Puerto(Instituto Maimónides de Investigación Biomédica de Córdoba), P. S. Laura(Instituto Maimónides de Investigación Biomédica de Córdoba), Alejandro Ibáñez‐Costa(Instituto de Salud Carlos III), Eduardo Collantes‐Estévez(Hospital Universitario Reina Sofía), P. Seguí Azpilcueta(Instituto Maimónides de Investigación Biomédica de Córdoba), M. Á. Aguirre(Instituto Maimónides de Investigación Biomédica de Córdoba), M. C. Ábalos‐Aguilera(Instituto Maimónides de Investigación Biomédica de Córdoba), I. Arias de la Rosa(Instituto Maimónides de Investigación Biomédica de Córdoba), J. P. Castaño Fuentes(University of Córdoba), M. Luque-Tévar(Instituto Maimónides de Investigación Biomédica de Córdoba), A. M. Patiño-Trives(Instituto Maimónides de Investigación Biomédica de Córdoba), Mario Espinosa(Instituto Maimónides de Investigación Biomédica de Córdoba)
Cited by 0
Related Papers
Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome
|Journal of Thrombosis and Haemostasis|2011|120
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas
|Cancer Letters|2015|91
Ghrelin gene products, receptors, and GOAT enzyme: biological and pathophysiological insight
|Journal of Endocrinology|2013|88
A Cellular and Molecular Basis for the Selective Desmopressin-Induced ACTH Release in Cushing Disease Patients: Key Role of AVPR1b Receptor and Potential Therapeutic Implications
|The Journal of Clinical Endocrinology & Metabolism|2013|81
Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro
|Journal of Endocrinology|2016|74